Woodline Partners »

Monte Rosa Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.2M 75k 16.45
2022-12-31 $3.9M 511k 7.61
2022-09-30 $4.1M 502k 8.17
2022-06-30 $3.6M 376k 9.67
2022-03-31 $674k 48k 14.01
2021-12-31 $981k 48k 20.43
2021-09-30 $3.0M 134k 22.28
2021-06-30 $4.7M 208k 22.70